HOME > TOP STORIES
TOP STORIES
-
BUSINESS Japan Drug Makers Fearing Manufacturing Crisis as Coronavirus Spreads
February 27, 2020
-
REGULATORY Zolgensma Now in Line for Japan Approval in March, All Eyes Now Riveted on Price
February 27, 2020
-
BUSINESS Fujifilm Receives Avigan Supply Requests from Overseas amid Coronavirus Outbreak
February 27, 2020
-
BUSINESS Drug Makers in Japan Upping Coronavirus Measures; Takeda Switches to Online Interviews for New R&D Hires
February 26, 2020
-
REGULATORY Japan Approves Label Expansions for Rozlytrek, Alecensa and More
February 25, 2020
-
BUSINESS “Tender Process Needs to Be Improved” in Response to Bid-Rigging Scandal by Top 4 Wholesalers: Hospital Management Advisor
February 25, 2020
-
ORGANIZATION Japan Pharma Lobbies Likely to Retain Chiefs as Off-Year Re-Pricing Debate Looms
February 21, 2020
-
BUSINESS Takeda Vaults to 9th in Global Pharma Ranking after Shire Buy, Roche Tops List: Jiho Tally
February 21, 2020
-
BUSINESS GSK Japan Resurrects “Sales” for Rep Performance Review, Doctor Payments; Critics Say It’s a Rollback
February 20, 2020
-
BUSINESS Japan Pharma Market Logs 1st Growth in 3 Years in 2019, Keytruda Is the Best-Seller: IQVIA
February 19, 2020
-
REGULATORY Authorized Generics for Memary, Celecox among Approval List towards June Listing
February 18, 2020
-
REGULATORY MHLW Panel to Review Nippon Shinyaku’s Oligonucleotide DMD Drug, Latuda and More on Feb. 28
February 18, 2020
-
REGULATORY Zolgensma Up for Japan Advisory Panel Meeting on Feb. 26, Listing Expected as Early as May
February 17, 2020
-
BUSINESS Eisai Pulls Belviq from US Market after FDA Flags Cancer Risks
February 17, 2020
-
REGULATORY MHLW to Weigh All-Year Invitation for Sakigake Requests: Top Pharmacy Officer
February 14, 2020
-
BUSINESS Ono Revamps Japan Sales Structure to Gear Up for New Launches
February 13, 2020
-
REGULATORY MHLW Calls for Stable Supplies of HIV Drugs amid Coronavirus Outbreak
February 13, 2020
-
BUSINESS With 2 New Deals Inked, Meiji Hunkering Down for Full-Scale Entry into Hematology Market
February 12, 2020
-
ORGANIZATION FPMAJ Creates Scheme to Deal with Drug Supply Disruptions; Companies to Set Up “Supply Adjustment Teams”
February 12, 2020
-
INTERVIEW Improper Materials Apparently Decreased after Promotion Guidelines Introduced: Pharmacist
February 10, 2020
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
